Multicenter Prospective Assessment of Coronary Microvascular Dysfunction: Primary Results of the FlowLab Study

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:

• Grant Support/Research Contract - Abbott; Amgen; AstraZenca; Pfizer; Ionis; Inari Medical
• Consultant Fee/Honoraria/Speaker's Bureau - Abbott; Abiomed; Terumo Medical Corporation; Bain Life Sciences, Endovascular Engineering, SpectraWAVE; Magenta Medical